Authors
Latest:
Isolated Extramedullary Relapse in Acute Lymphoblastic Leukemia: What Can We Do Before and After Transplant?The case of a 43-year-old male with a history of B-cell acute lymphoblastic leukemia.
Latest:
Isolated Extramedullary Relapse in Acute Lymphoblastic Leukemia: What Can We Do Before and After Transplant?The case of a 43-year-old male with a history of B-cell acute lymphoblastic leukemia.
Latest:
CARTITUDE-4 Study: Cilta-Cel vs Standard of Care for Lenalidomide-Refractory Multiple MyelomaPanelists review the CARTITUDE-4 study results highlighting the efficacy of cilta-cel in lenalidomide-refractory multiple myeloma, addressing implementation challenges and patient preferences in varying relapse scenarios.
Latest:
Unmet Needs and Future Perspectives in Treatment Sequencing Strategies in R/R MMThe panel concludes its discussion with key takeaways on unmet needs and evolving treatment paradigms in relapsed/refractory multiple myeloma.
Latest:
Rogerio Lilenbaum, MD, Discusses Immunotherapy and Targeted Therapy for Lung CancerRogerio Lilenbaum, MD, talked about the state of lung cancer in regards to immunotherapy and targeted therapy at the 17th Annual Winter Lung Conference in Miami Beach, Florida.
Latest:
Walter Curran, MD, on Integration of Immunotherapy with Radiation TherapyWalter Curran, MD, detailed his presentation on immunotherapy and radiation therapy, and how integrating the 2 treatment options presents an exciting opportunity moving forward.
Latest:
Andrea Price, APN, Discusses Electronic Medical Records in CAR T-Cell TherapyThe associate director for clinical research at the Washington University School of Medicine spoke about the value and challenges of using EMRs in CAR T-cell therapy.
Latest:
Dylan Essner on Documentation Tools for CAR T-Cell TherapyDylan Essner discussed the implementation of documentation tools and CRS, ICANS and ICE flow sheets within CAR T-cell therapy.
Latest:
Mark Schroeder, MD, Discusses Treatment Options for Acute GvHDMark Schroeder, MD, detailed 3 different potential treatments for acute graft versus host disease.
Latest:
Madan Jagasia, MBBS, MS, on Ruxolitinib to Treat Steroid Refractory GvHDMadan Jagasia, MBBS, MS, of the Vanderbilt University Medical Center discussed the next steps in treating acute graft versus host disease with ruxolitinib.
Latest:
Kevin Hughes, MD, on Breast Cancer Treatment Moving ForwardThe breast cancer expert spoke about decreasing the amount of treatment to receive the same impact for patients with breast cancer.
Latest:
Hope S. Rugo, MD, Talks Aromatase Inhibitors Plus Ribociclib in HR+/HER2– Advanced Breast CancerHope S. Rugo, MD, FASCO, gave an overview of ribociclib plus aromatase inhibitor use vs abemaciclib plus aromatase inhibitors for patients with hormone receptor-positive, HER2-negative advanced breast cancer.
Latest:
Patricia Jakel, RN, MN, AOCN, On Treating Patients with CDK 4/6 InhibitorsThe clinical nurse specialist was also diagnosed with stage III invasive lobular breast cancer and was treated with CDK 4/6 inhibitors, giving her the unique opportunity to speak to both the patient and clinical perspective.
Latest:
The Relationship Between Checkpoint Inhibitors and the Gut Microbiome and Its Application in Prostate CancerThis review article discusses the concepts of a tumor microenvironment and a gut microbiome and their effects on responses to checkpoint inhibitors (CPIs). It also reviews recent research investigating these 3 topics, and how it can be applied to using CPIs in prostate cancer.
Latest:
The Relationship Between Checkpoint Inhibitors and the Gut Microbiome and Its Application in Prostate CancerThis review article discusses the concepts of a tumor microenvironment and a gut microbiome and their effects on responses to checkpoint inhibitors (CPIs). It also reviews recent research investigating these 3 topics, and how it can be applied to using CPIs in prostate cancer.
Latest:
Pneumocystis jirovecii Pneumonia in Patients With Metastatic Prostate Cancer on Corticosteroids for Malignant Spinal Cord Compression: Two Case Reports and a Guideline ReviewTwo case reports and a review of PCP in patients with solid tumors.
Latest:
Pneumocystis jirovecii Pneumonia in Patients With Metastatic Prostate Cancer on Corticosteroids for Malignant Spinal Cord Compression: Two Case Reports and a Guideline ReviewTwo case reports and a review of PCP in patients with solid tumors.
Latest:
Pneumocystis jirovecii Pneumonia in Patients With Metastatic Prostate Cancer on Corticosteroids for Malignant Spinal Cord Compression: Two Case Reports and a Guideline ReviewTwo case reports and a review of PCP in patients with solid tumors.
Latest:
Hepatocellular Carcinoma Recurrence After Liver TransplantationThe case of a 64-year-old white woman with hepatitis C virus infection-related well-compensated cirrhosis with hepatocellular carcinoma recuurence.
Latest:
How to Radiologically Assess and Follow Response After Treatment of Hepatocellular CarcinomaA thought-provoking installment of Clinical Quandaries is presented by Alejandro Gabutti, MD; and Tommaso Cascella, MD, of a 36-year-old patient with hepatitis C virus-related cirrhosis and a subsequent diagnosis of hepatocellular carcinoma.
Latest:
Hepatocellular Carcinoma Recurrence After Liver TransplantationThe case of a 64-year-old white woman with hepatitis C virus infection-related well-compensated cirrhosis with hepatocellular carcinoma recuurence.
Latest:
Recurrent Small Cell Carcinoma of the Lung With Cutaneous Metastasis in BreastExperts present a case of recurrent small cell lung cancer presenting with a cutaneous metastatic nodule in the right breast.
Latest:
69-Year-Old Man With Castration-Resistant Prostate Cancer Progressing After Docetaxel and Androgen Receptor-Targeting AgentExperts discuss the case of a 69-year-old man with a history of metastatic prostate cancer previously treated with androgen deprivation therapy with leuprolide.
Latest:
69-Year-Old Man With Castration-Resistant Prostate Cancer Progressing After Docetaxel and Androgen Receptor-Targeting AgentExperts discuss the case of a 69-year-old man with a history of metastatic prostate cancer previously treated with androgen deprivation therapy with leuprolide.
Latest:
HPV and the Immune System in Head and Neck Cancers: Therapeutic ConsiderationsA review of the role of immune therapy in HPV-associated head and neck squamous cell carcinoma, along with the evidence and perspective behind differing therapeutic considerations.
Latest:
Chemotherapy Drug Shortages: It’s SolubleHoward S. Hochster, MD, reviews the potential solutions for the current chemotherapy drug shortages, and how this can be avoided in the future.
Latest:
MAIC Study Finds Similar Results With Linvoseltamab/Teclistamab in R/R Multiple MyelomaSimilar outcomes were noted when linvoseltamab and teclistamab were analyzed as treatments for patients with relapsed/refractory multiple myeloma.
Latest:
Defining PSA Nadir After Definitive Therapy in Prostate CancerBrian Helfand, MD, PhD, describes the ways in which the PSA nadir can be defined after definitive therapy and the implications of the definition used for patients with prostate cancer.
